Changes in the treatment of pediatric cancer over recent decades have translated to a reduced risk of serious, long-term late health effects of cancer therapy. This is according to the latest analysis from the Childhood Cancer Survivor Study (CCSS), a National Cancer Institute-funded resource for late-effects research, led by investigators at St. Jude Children’s Research Hospital.
“This is the first comprehensive study to demonstrate how changes in treatments over time have impacted the occurrence of late effects experienced by childhood cancer survivors,” said Todd Gibson, Ph.D., assistant member of the Department of Epidemiology and Cancer Control at St. Jude. “We found the 15-year cumulative incidence of people reporting at least one severe health condition decreased from 12.7 percent among childhood cancer survivors diagnosed in the 1970s to 10.1 percent for those diagnosed in the 1980s to 8.8 percent in the 1990s–a statistically significant decline.”
To view the multimedia release go to:
https://www.multivu.com/players/English/7924756-st-jude-childhood-cancer-survivorship-asco-2017/
A new survey from Alcon, the global leader in eye care and a division of Novartis, demonstrates that people experience significant emotional and lifestyle benefits after cataract surgery. Nearly three in four respondents who expressed an opinion agreed that after having the surgery, they were happier, more satisfied and had a greater appreciation for life. The survey also confirmed that life before surgery posed several daily challenges. A majority of survey respondents said cataracts made simple, day-to-day tasks harder, and made them feel annoyed, frustrated and old.
In recognition of Cataract Awareness Month this June, Alcon conducted the MyCataracts survey with 1,300 US adults, age 60 and over, who have undergone cataract surgery, to better understand the emotional journey of the condition and the lifestyle benefits of treatment. The survey expands Alcon’s ongoing MyCataracts awareness campaign by uncovering insights that will help people make informed treatment decisions together with their doctors.
To view the multimedia release go to:
https://www.multivu.com/players/English/8068751-alcon-pharmaceuticals-my-cataracts-eye-care/
Jason’s Deli and The University of Texas MD Anderson Cancer Center proudly introduce the new Salmon Pacifica Salad as part of an ongoing alliance to raise money to help end cancer for patients and families around the world.
Now through April 2018, 50 cents from the sale of every Salmon Pacifica Salad at participating Jason’s Deli restaurants will be donated to MD Anderson to support cancer prevention research and programs.
To view the multimedia release go to:
https://www.multivu.com/players/English/8102251-jasons-deli-md-anderson-cancer-center-salmon-pacifica-salad/
Institut Marquès presents the 1000th birth of its international embryo adoption programme. It is a baby girl called Georgina who, with 3,500 kg. of weight, was born in the town of Essex (UK) last February. Her mother decided to adopt an embryo at Institut Marquès, a clinic in Barcelona, after having performed several cycles of assisted reproduction without success in different centres. In June, an embryo that had been frozen for years was transferred; it came from the treatment of a couple who did not answer about the destination they wanted for their embryos and they were thus left under the custody of the clinic.
Kerry Andersen, Georgina's mother, is a midwife. A 45-year-old single woman who believes that this treatment has given her "the best of my life, which was the hope of being a mother. I am thrilled to think that my precious daughter is here thanks to the embryo adoption programme as I feel it is a very special way to enjoy motherhood. When I got to know this program, I did not hesitate to adopt an embryo”.
To view the multimedia release go to:
https://www.multivu.com/players/uk/8112351-institut-marques-women-spain-adopt-embryos/
In a glittering venue hosted at The Athens Concert Hall on May 15, 2017, attended by State officials and business representatives from all sectors of the economy, Mr. Gabriel Chaleplis was honoured for his international entrepreneurship.
The award to Mr. Gabriel Chaleplis was presented by Mr. Elias Xanthakos, Secretary General of The Greek Ministry of Economy and Development.
The award was presented for the first time in Greece, in order to honour international entrepreneurs of Greek origin who have demonstrated success, ethics, an international mind-set, and major achievements on global level.
To view the multimedia release go to:
https://www.multivu.com/players/uk/8111251-b2b-gaming-gabriel-chaleplis-entrepreneur/
Renault ZOE is the first car to be designed as an all-electric model. A city car ideal for everyday use, it boasts the latest technology. Renault ZOE ships with six world firsts, designed to make it an easy-to-drive connected car with significant range. Revealed at the Geneva Motor Show in 2012, Renault ZOE will be available in three versions (Life, Zen and Intens) at end-2012.
Driving Renault ZOE is a new and enjoyable automotive experience. The wound rotor synchronous electric motor develops 65 kW with maximum torque of 220 Nm delivered instantly. ZOE combines strong acceleration and pick-up from the lowest engine speeds with a range of 210 km over an NEDC cycle.
// Renault ZOE est la première voiture conçue pour être 100 % électrique et idéale pour les usages quotidiens. Cette citadine intègre la technologie la plus avancée à travers six premières mondiales au service de la simplicité d'utilisation, de l'autonomie et de la connectivité. Révélée au salon de Genève 2012, Renault ZOE sera commercialisée dans trois versions différentes (Life, Zen et Intens) fin 2012.
Conduire Renault ZOE est une nouvelle expérience automobile, source de plaisirs. Le moteur électrique synchrone à rotor bobiné d'une puissance de 65 kW délivre instantanément un couple maximum de 220 Nm. Les accélérations et les reprises sont franches dès les bas régimes. Elle affiche par ailleurs, une autonomie de 210 km en cycle NEDC.
The ZOE establishes a new record driving range of 400km 100% electric (NEDC).
Renault has introduced a new Z.E. 40 battery for ZOE. At the same, ZOE owners can benefit from a range of new connected services and equipment upgrades. Order books for the new ZOE line-up are open. The new ZOEs fitted with the new Z.E. 40 battery are made at Renault’s Flins plant in France and will be available for delivery before the end of the year.
St. Jude Children’s Research Hospital patients who completed kindergarten during their treatment for pediatric cancers celebrated at a graduation ceremony.
For the 10th straight year, St. Jude honored 14 patients from around the United States who completed kindergarten while battling life-threatening illnesses like leukemia and brain tumors. Dozens of families and St. Jude doctors, nurses, and staff cheered for the young students, who completed kindergarten in the St. Jude School Program by Chili’s.
Each year, the school program commemorates students who have completed kindergarten coursework with a special ceremony. The children present a song for the families and St. Jude staff, receive their diplomas and celebrate the milestone with their fellow students.
To view the multimedia release go to:
https://www.multivu.com/players/English/7924755-st-jude-celebrates-kindergarten-graduation/
GW Pharmaceuticals plc (Nasdaq: GWPH, “GW,” “the Company” or “the Group”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, along with its U.S. subsidiary Greenwich Biosciences, announced today that The New England Journal of Medicine has published results from a Phase 3 study of Epidiolex® (cannabidiol) in children with Dravet syndrome.1 Epidiolex, GW’s lead product candidate and the potential first in a new category of anti-epileptic drugs, is a liquid formulation of purified, plant-derived cannabidiol (CBD), a non-psychoactive cannabinoid, which is being studied for the treatment of a number of rare, severe pediatric-onset epilepsy disorders. In the study, Epidiolex significantly reduced monthly convulsive seizure frequency compared to placebo in highly treatment-resistant children when added to existing treatment. Treatment with Epidiolex was generally well tolerated, with a safety profile consistent with prior open label experience.
To view the multimedia release go to:
https://www.multivu.com/players/uk/8109951-gw-pharmaceuticals-study-epidiolex/
Step right up to witness the greatest “big top” celebration the world has ever seen. The 14th Annual Avon Heritage Duck Tape® Festival sets up Father’s Day weekend – Friday, June 16 through Sunday, June 18, 2017 – with a theme to entertain men, women and children of all ages. That’s right, folks, the Duck Tape® “circus” is coming to town!
Available in hundreds of colors, designs and licenses, America’s favorite fix-all is ready for the spotlight. Head out to Veterans Memorial Park in Avon, Ohio to be amazed, amused and astonished by a most-incredible Duck Tape® “Circus Spectacular”: from a circus-themed parade featuring floats made with Duck Tape®, larger-than-life Duck Tape® sculptures to lots of fun under the arts and crafts tent and a community fashion show. Families can also enjoy delicious fair food favorites (cotton candy, anyone?), rides and attractions, including family-friendly games, live entertainment and more. Plus, the first 500 spectators each day will receive a free roll of Duck Tape®.
To view the multimedia release go to:
https://www.multivu.com/players/English/8109351-duck-tape-avon-heritage-festival-circus-spectacular/
Piano legend Byron Janis releases Byron Janis Live on Tour, an album of never before released live recordings of performances by the internationally celebrated pianist. It is Maestro Janis’ first release of new material in twenty years and celebrates the 70th anniversary of his very first RCA LP recording in 1947 at the age of 19 titled Bach/Liszt, Chopin. Byron Janis Live on Tour is an exclusive compilation of twelve works composed by Haydn, Chopin & Liszt. Also featured are two pieces composed for stage and screen by Janis himself, a “hot” collaboration on two pianos with Cy Coleman and, finally, a song he composed, “David’s Star,” for which his son Stefan wrote the lyrics. This album is dedicated to him, who died tragically of a heart attack in February of this year. The album is due to be released by Janis Eleven Enterprises, LTD on May 23 in honor of his 89th birthday which was celebrated on March 24, 2017. Each Volume will have a limited edition pressed vinyl release.
This release is the first of a three CD release musical journey. In the fall, Maestro Janis will release “Live from Leningrad,” a recording made in the early sixties in Russia. This was recorded unbeknownst to him while he was serving as a US Cultural Ambassador to the Soviet Union and surreptitiously presented to him nearly sixty years later. Then, just in time for the holidays, Byron Janis Live on Tour, Volume II will be available. Similar in format to Volume I, it will include a compilation of live recordings of performances of Mr. Janis from all over the world.
To view the multimedia release go to:
https://www.multivu.com/players/English/8108051-byron-janis-live-on-tour-volume-one/
Hunova, the first robotic gym for the rehabilitation and functional motor sense evaluation of lower limbs and trunk, has been officially launched in Genoa, Italy. The first 30 robots will be available from June in Europe and the USA. The technology was developed and patented at the IIT laboratories and has been launched on the market thanks to a 10 million euro investment from entrepreneur Sergio Dompè.
Hunova is a programmable robotic medical device that allows professionals in the geriatrics, neurology and sport rehabilitation field to cure and predict many neurological and orthopedic conditions. There are two main competitive advantages of this technology: Hunova is able to collect a significant amount of data on biomechanics, constantly monitoring the patient’s progress. Secondly, it provides direct support to the patient through a guiding robotic system, offering a wide range of rehabilitation protocols in the form of video games. It consists of two electromechanical platforms equipped with sensors, characterized by two degrees of freedom (feet and seat level). The device integrates the force sensors to adjust the interaction with the patient and a wireless sensor, which is placed on the patient’s trunk, allowing the physiotherapist to check the movement of the torso.
To view the multimedia release go to:
https://www.multivu.com/players/uk/8108951-iit-movendo-launch-robot-hunova/
